Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2014 | 09-2013 | 09-2012 | 09-2011 | 09-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 323 | 10 | 28 | 12 | 429 |
| Receivables | 39 | 0 | 49 | 16 | 11 |
| TOTAL | $442 | $10 | $77 | $33 | $450 |
| Non-Current Assets | |||||
| PPE Net | N/A | 1 | 1 | 368 | 2 |
| Investments And Advances | 61 | 42 | 28 | 28 | N/A |
| Intangibles | 1,440 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 5 | 29 | 0 | 0 | 28 |
| TOTAL | $1,506 | $71 | $29 | $396 | $30 |
| Total Assets | $1,947 | $81 | $106 | $429 | $480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 119 | 51 | 37 | N/A | N/A |
| TOTAL | $133 | $173 | $52 | $422 | $1,695 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 29 | 29 | 0 | 62 | 58 |
| TOTAL | $29 | $29 | $0 | $62 | $58 |
| Total Liabilities | $161 | $202 | $52 | $483 | $1,753 |
| Shareholders' Equity | |||||
| Retained earnings | -1,654 | -21,223 | -21,048 | -21,157 | -18,488 |
| Other shareholders' equity | 174 | 0 | 0 | 0 | 0 |
| TOTAL | $1,786 | $-120 | $54 | $-54 | $-1,273 |
| Total Liabilities And Equity | $1,947 | $81 | $106 | $429 | $480 |